delirium case presentation. case 93 ♂ pc 4/7 confusion, agitation + general deterioration 3/7...
TRANSCRIPT
O/A
Temp 35.8 Dehydrated GCS 13/15 AMTS 7/10 Urine
offensive odour Dip +ve blood, leukocytes, nitrites
Day 2
GCS 7/15
CT Brain Small vessel ischaemia No evidence of space occupying lesion,
intracranial haemorrhage or skull #
CRP 46
Delirium
Transient global disorder of cognition
Medical emergency Affects 20% patients on general
wards Affects 30% of elderly medical
patients Associated with increased mortality,
increased nursing, failed rehab and delayed discharge
Presentation
Acute + relatively sudden onset (over hours to days)
Decline in attention-focus, perception and cognition
Change in cognition must not be one better accounted for by dementia
Fluctuating time course of delirium helps to differentiate
Characterised by:
Disorientation in time, place +/- person Impaired concentration + attention Altered cognitive state Impaired ability to communicate Wakefulness – insomnia + nocturnal
agitation Reduced cooperation Overactive psychomotor activity –
irritability + agression
Diagnosis
Cannot be made without knowledge of baseline cognitive function
Can be confused with 1. dementia – irreversible, not assd with
change in consciousness 2. depression 3. psychosis – may be overlap but
usually consciousness + cognition not impaired
Differentiating features of delirium and dementia
Features Delirium Dementia
Onset Acute Insidious
Course Fluctuating Progressive
Duration Days – weeks Months - years
Consciousness Altered Clear
Attention Impaired Normal (unless severe)
Psychomotor changes
Increased or decreased
Often normal
Reversibility Usually Rarely
Risk factors in elderly
Age >80 Extreme physical frailty Multiple medical problems Infections (chest + urine) Polypharmacy Sensory impairment Metabolic disturbance Long-bone # General anaesthesia
Risk factors
Dementia is one of the most consistent risk factors
Underlying dementia in 25-50% Presence of dementia increases risk
of delirium by 2-3 times
Causes
Severe physical or mental illness or any process interfering with normal metabolism or function of the brain
Causes mnemonic Infections (pneumonia, UTI) Withdrawl (alcohol, opiate) Acute metabolic (acidosis, renal failure) Trauma (acute severe pain) CNS pathology (epilepsy, cerebral haemorrhage) Hypoxia Deficiencies (B12, thiamine) Endocrine (thyroid, PTH, hypo/hyperglycaemia) Acute vascular (stroke, MI, PE, heart failure) Toxins/drugs (prescribed tramadol, dig toxicity,
antidepressants, anticholinergics, corticosteroids) recreational)
Heavy metals
Pathophysiology
Not fully understood Main theory = reversible impairment of cerebral
oxidative metabolism + neurotransmitter abnormalities
Ach – anticholinergics = cause of acute confusional states + Pts with impaired cholinergic transmission (eg Alzheimers) are more susceptible
Dopamine – excess dopamine in delirium Serotonin – increased in delirium Inflammatory mechanism – cytokines eg
interleukin-1 release from cells Stress reaction + sleep deprivation Disrupted BBB may cause delirium
Management
1. Identify + treat underlying cause (return to pre-morbid state can take up to 3 weeks)
2. Complete lab tests + investigations eg. FBC, CRP, U+Es, BM, LFTs, TFTs, B12, MSU, CXR
3. Rule out EtOH withdrawl 4. Assume an underlying organic
cause
Management
5. Ensure adequate hydration + nutrition
6. Use clear, straightforward communication
7. Orientate the patient to environment + frequent reassurance
8. Identify if environmental factors are contributing to confused state
Management
Disturbed, agitated or uncooperative patients often require additional nursing input
Medication should not be regarded as first line treatment
Consider medication if all other strategies fail but remember all psychotropic meds can increase delirium + confusion
Medications
Benzodiazepines Lorazepam 0.5-1mg tds orally Shorter half life than diazepam +
effective at lower doses S/E - Respiratory depression, increased
risk of falls, hypotension Not for long term use
Medications
Antipsychotics Avoid in PD Haloperidol 0.5-1mg S/E – cardiac, avoid in patients with
hypotension, tachycardia + arrhythmias, extrapyramidal
Recent evidence suggests not to use in patients with dementia or risk of CVD due to increased risk of cerebral ischaemia
3X increase in risk of stroke when Risperidone used in older patients with dementia
Medications
Dementia with Lewy Bodies Severe reactions to antipsychotic drugs
that can lead to death Due to extrapyramidal effects
Urgent psychiatric opinion
Medication
Review regime every 48h Will not improve cognition Can reduce behavioural disturbance Start with lowest dose possible +
increase gradually Offer orally first Use as ‘fixed dose’ regime
Complications
Malnutrition Aspiration pneumonia Pressure ulcers Weakness, decreased mobility,
decreased function Falls, #s
Outpatient Care
Memories of delirium are variable Educate patient, family + carers
about future risk factors Elderly patients can require at least
6-8 weeks for a full recovery For some patients the cognitive
effects may not resolve completely